Colorectal cancer screenings at a younger age help lower risk and cost of care
Screenings can help mitigate the health and cost impact of rising cases among adults under the age of 50.
Read More
Immune checkpoint inhibitor medications: A game-changer in cancer treatments
A report from the Evernorth Research Institute offers insights that can help health plans optimize cancer care.
Read More
Pharmacy in Focus: Navigating GLP-1 demand, cost, and sustainability
With demand and utilization expanding, comprehensive clinical support and cost-management strategies are crucial to ensuring accessibility and safeguarding health care budgets.
Read More
More cervical cancer screenings. More lives saved.
Improving access to regular cervical cancer screenings, especially for women in underserved communities, is key to reducing mortality rates.
Read More
Respiratory illnesses are on the rise this season across the U.S.
Evernorth data shows fewer prescriptions have been filled for certain anti-viral medications than in previous years, but an uptick in January shows that respiratory illnesses are circulating in the U....
Read More
Research finds that few women receive diagnoses of perimenopause or menopause
An Evernorth analysis found that more than half of women ages 40 through 64 had experienced symptoms related to perimenopause or menopause, yet only 8% of the women had received a confirmed diagnosis....
Read More